A data-manipulation episode involving a drug that costs $2.1 million tests an executive who is trying to rebuild trust in the company
Novartis AG Chief Executive Vas Narasimhan has spent part of his 18 months at the helm of the drug giant cleaning up issues that emerged before his watch. Now, he is facing a storm of his own making.
Dr. Narasimhan said on a call with analysts earlier this month that the company kept a data-manipulation issue under wraps while the Food and Drug Administration completed its review of Novartis’s Zolgensma, the world’s most expensive drug. The Swiss company has said it wanted to finish its own review before alerting the FDA,...
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Cathay Pacific Airways CEO Rupert Hogg resigns as Chinese scrutiny mountsCathay Pacific Airways CEO Rupert Hogg resigned in a shock move on Fri...
Leer más »
GE rebounds after CEO share purchases, Wall Street analysts come to company's defenseGE bounced back Friday after the CEO shored up confidence in buying a bulk of company shares, and analysts defended the industrial giant.
Leer más »
Cathay CEO resigns amid Hong Kong protest blowback as more rallies plannedThe boss of Hong Kong carrier Cathay Pacific Airways quit on Friday, the highest...
Leer más »
Cathay Pacific CEO resigns after Beijing pressureThe CEO of Cathay Pacific Airways, one of Hong Kong&39;s most prominent companies, resigned Friday following pressure by Beijing on the carrier over participation by some of its employees in anti-government protests. Rupert Hogg became the highest-profile corporate casualty of official Chinese pressure
Leer más »
BMW's CEO urges staff to narrow sales gap with MercedesBMW's new chief executive urged employees to embrace change and to find inn...
Leer más »